Barkhausen et al. reported that in a murine polymicrobial sepsis model, pretreatment with a selective inhibitor of IL-6 trans-signalling increased survival from 45 to 100% in a dose-dependent manner [49]. This evidence concerns the gene IL6 and Sepsis.